Literature DB >> 9440646

Intracolonic release of nitric oxide during trinitrobenzene sulfonic acid rat colitis.

M Ferretti1, P Gionchetti, F Rizzello, A Venturi, P Stella, F Corti, J Mizrahi, M Miglioli, M Campieri.   

Abstract

Nitric oxide is thought to play an important role in modulating the inflammatory process. Recently an increase in the inducible form of nitric oxide synthase (iNOS) has been found in the rat trinitrobenzene sulfonic acid model of experimental colitis, and inhibition of nitric oxide synthase activity resulted in an amelioration of tissue injury. The aim of our study was to evaluate in vivo intracolonic release of nitric oxide in this model of colitis. Experimental colitis was induced in male Sprague-Dawley rats by a single intracolonic administration of trinitrobenzene sulfonic acid. Nitrite levels were determined in rectal dialysates by HPLC. The tissue myeloperoxidase and iNOS and the luminal leukotriene B4 were also measured. Nitrite levels were significantly increased in rectal dialysates during colitis and correlated significantly with tissue myeloperoxidase and iNOS activity. The correlation between nitrite dialysate levels and wall iNOS activity confirms that nitrite in dialysates is produced by inflammatory cells and not by colonic bacterial flora. Determination of nitrite levels in rectal dialysates seems a valuable method to monitor colonic inflammation in rat trinitrobenzene sulfonic acid colitis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9440646     DOI: 10.1023/a:1018897519880

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  22 in total

1.  Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme.

Authors:  D S Bredt; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

Review 2.  Signal transduction mechanisms involving nitric oxide.

Authors:  L J Ignarro
Journal:  Biochem Pharmacol       Date:  1991-02-15       Impact factor: 5.858

3.  Enhanced systemic nitric oxide production in inflammatory bowel disease.

Authors:  D D Tran; J J Visser; M O Pool; M A Cuesta; K Hoekman; A S Peña; S G Meuwissen
Journal:  Lancet       Date:  1993-05-01       Impact factor: 79.321

Review 4.  Nitrite from inflammatory cells--a cancer risk factor in ulcerative colitis?

Authors:  W E Roediger; M J Lawson; B C Radcliffe
Journal:  Dis Colon Rectum       Date:  1990-12       Impact factor: 4.585

5.  Participation of thromboxane and other eicosanoid synthesis in the course of experimental inflammatory colitis.

Authors:  J Vilaseca; A Salas; F Guarner; R Rodriguez; J R Malagelada
Journal:  Gastroenterology       Date:  1990-02       Impact factor: 22.682

6.  Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease.

Authors:  D Rachmilewitz; J S Stamler; D Bachwich; F Karmeli; Z Ackerman; D K Podolsky
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

7.  Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity.

Authors:  D Rachmilewitz; F Karmeli; E Okon; M Bursztyn
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

8.  Increased nitric oxide synthesis in ulcerative colitis.

Authors:  S J Middleton; M Shorthouse; J O Hunter
Journal:  Lancet       Date:  1993-02-20       Impact factor: 79.321

Review 9.  Nitric oxide as a mediator of nonadrenergic noncholinergic neurotransmission.

Authors:  K M Sanders; S M Ward
Journal:  Am J Physiol       Date:  1992-03

10.  Pathological and therapeutic implications for nitric oxide in inflammatory bowel disease.

Authors:  N K Boughton-Smith
Journal:  J R Soc Med       Date:  1994-06       Impact factor: 18.000

View more
  8 in total

1.  Induction of iNOS in a rat model of acute colitis.

Authors:  E Kankuri; M Z Asmawi; R Korpela; H Vapaatalo; E Moilanen
Journal:  Inflammation       Date:  1999-04       Impact factor: 4.092

2.  Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice.

Authors:  F Obermeier; G Kojouharoff; W Hans; J Schölmerich; V Gross; W Falk
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

3.  Treatment with Mesna and n-3 polyunsaturated fatty acids ameliorates experimental ulcerative colitis in rats.

Authors:  Ioannis Triantafyllidis; Theofilos Poutahidis; Ioannis Taitzoglou; Isaak Kesisoglou; Charalampos Lazaridis; Dimitrios Botsios
Journal:  Int J Exp Pathol       Date:  2016-01-19       Impact factor: 1.925

4.  Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis.

Authors:  A Ukil; S Maity; S Karmakar; N Datta; J R Vedasiromoni; Pijush K Das
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

5.  Effect of the antioxidant Mesna (2-mercaptoethane sulfonate) on experimental colitis.

Authors:  T Shusterman; S Sela; H Cohen; B Kristal; W Sbeit; R Reshef
Journal:  Dig Dis Sci       Date:  2003-06       Impact factor: 3.199

6.  Kefir treatment ameliorates dextran sulfate sodium-induced colitis in rats.

Authors:  Altug Senol; Mehmet Isler; Recep Sutcu; Mete Akin; Ebru Cakir; Betul M Ceyhan; M Cem Kockar
Journal:  World J Gastroenterol       Date:  2015-12-14       Impact factor: 5.742

7.  Evaluation of in vivo efficacy and toxicity of prednisolone-loaded hydrogel-based drug delivery device.

Authors:  Amit Kumar De; Plaban Bhattacharya; Sriparna Datta; Arup Mukherjee
Journal:  Int J Pharm Investig       Date:  2013-10

8.  Application of an amine functionalized biopolymer in the colonic delivery of glycyrrhizin: a design and in vivo efficacy study.

Authors:  Amit Kumar De; Sriparna Datta; Arup Mukherjee
Journal:  Sci Pharm       Date:  2013-05-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.